脑部放疗，上午比下午敏感许多！
9 Y- d- T( ~5 V: C1 F7 Y
2 ]4 ^, K; U. y9 ]
+ L p! L' p; bCancer 2011 Jan 15;117(2):414-20. doi: 10.1002/cncr.25423. Epub 2010 Sep 9.' }5 W9 L/ m F9 j4 _
Gamma knife radiosurgery for brain metastasis of nonsmall cell lung cancer: is there a difference in outcome between morning and afternoon treatment?4 c; n" z) c2 C$ D& G4 w$ U% }
Rahn DA 3rd, Ray DK, Schlesinger DJ, Steiner L, Sheehan JP, O'Quigley JM, Rich T.
k& W! D8 D% Z' ySourceDepartment of Radiation Oncology, University of Virginia Health Sciences Center, Charlottesville, Virginia 22908, USA.
. [) C; R. c# J& j1 }! l% y5 K+ r$ j5 c5 z) _( W
Abstract# F" N' D% u/ i+ j6 j7 e
BACKGROUND: Circadian cell-cycle progression causes fluctuating radiosensitivity in many tissues, which could affect clinical outcomes. The purpose of this study was to determine whether outcomes of single-session gamma knife radiosurgery (GKRS) for metastatic nonsmall cell lung cancer (NSCLC) differ based on treatment time.
A# v. `9 ~8 u6 ~: |+ |9 B& U. C' x- _5 u. `2 S6 }0 M
METHODS: Fifty-eight patients received GKRS between 10:00 am and 12:30 pm and 39 patients received GKRS between 12:30 pm and 3:00 pm. The mean peripheral dose was 18.6 Gy. The mean tumor size was 7.3 cm³. Magnetic resonance imaging was used to score local control at 3 months. Cause of death (COD) was categorized as central nervous system (CNS)-related or systemic.
$ A* Q0 F4 V! v# I/ Z
6 u7 s3 J( M8 R' y4 N* _& QRESULTS: Demographic and disease characteristics of the 2 groups were similar. Local control at 3 months was achieved in 97% (35/36) of patients who underwent GKRS early in the day versus 67% (8/12) of patients who underwent GKRS later in the day (chi-square, P = .014). Early GKRS was associated with better survival (median 9.5 months) than late GKRS (median 5 months) (Kaplan-Meier log-rank test, P = .025). Factors contributing to better survival in a Cox regression model included early treatment time (P = .004) and recursive partition analysis class (P < .001). Cause of death in the early treatment group was CNS-related in 6% (3/47) of patients versus 24% (8/34) of patients in the late treatment group (chi-square test, P = .026).. N/ \+ c4 l1 f3 J, c" Q$ j
$ A8 \$ C7 K/ r Z' S+ C
CONCLUSIONS: GKRS for metastatic NSCLC had better local control, better survival, and a lower rate of CNS-related cause of death when given earlier in the day versus later in the day. These retrospective data should encourage future study in brain radiosurgery and non-CNS stereotactic body radiotherapy series.
9 m% X9 Y8 |7 y n V' B
% [# ?2 \, r: z3 t% q |
显身卡
